6Indexed trials
drug · Product Intelligence
Ocrelizumab
Pipeline Intelligence
Ocrelizumab: 6 indexed trials, 4 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
4Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT02637856Genentech, Inc. · multiple_sclerosisPHASE3
NCT03593590Hoffmann-La Roche · multiple_sclerosisCOMPLETED
NCT03873389Johns Hopkins University · multiple_sclerosisCOMPLETED
NCT04544436Hoffmann-La Roche · multiple_sclerosisPHASE3
NCT04874597Dr Recai Turkoglu · multiple_sclerosisUNKNOWN
NCT05123703Hoffmann-La Roche · multiple_sclerosisPHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.